<DOC>
	<DOCNO>NCT01142050</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety treatment Insulin Resistance Type 2 Diabetes Mellitus Bone Marrow Mesenchymal Stem Cells .</brief_summary>
	<brief_title>Stem Cell Therapy Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>- To evaluate feasibility safety transplantation treatment use umbilical cord mesenchymal stem cell patient type 2 diabetes mellitus undergoing insulin injection treatment . - To assess efficacy transplantation treatment use umbilical cord mesenchymal stem cell patient type 2 diabetes mellitus .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Free take part study ability provide write informed consent ; 2 . Type 2 diabetes mellitus ( guideline WHO , 1999 ) ; 3 . Age 1875 year old，Male/Female ; 4 . 19≤Body mass index ( BMI ) ≤30㎏/㎡ ; 5 . Fast blood glucose ( FBG ) ≥7.0 mmol/L , HbAc1≥7％ ; 6 . Intravenous insulin tolerance test（ITT）indicate patient insulin resistance ; 7 . Not pregnant nursing ; 8 . Negative pregnancy test ; 9 . Fertile patient use effective contraception . 1 . Severe concurrent medical condition ( e.g. , serious heart disease , lung disease , hematopoietic dysfunction , liver dysfunction , kidney dysfunction ) ; 2 . Active infection require treatment ; 3 . Unexplained febrile illness ; 4 . Known immunosuppressive disease , e.g . HIV infection , hepatitis B C infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>stem cell ;</keyword>
	<keyword>diabetes mellitus ;</keyword>
	<keyword>treatment .</keyword>
</DOC>